HYPRO_2A: HYPRO, figure 2A

HYPRO_2AR Documentation

HYPRO, figure 2A

Description

Kaplan-Meier digitized data from HYPRO, figure 2A (PMID 27339116). A reported sample size of 804 for a primary endpoint of RFS in prostate cancer.

Usage

HYPRO_2A

Format

A data frame of 804 observations and 3 variables:

time event time (in months)
event RFS event indicator (0: no event, 1: event)
arm treatment arms (conventional fractionated, hypofractionated)

Source

Incrocci L, Wortel RC, Alemayehu WG, et al. Hypofractionated versus conventionally fractionated radiotherapy for patients with localised prostate cancer (HYPRO): final efficacy results from a randomised, multicentre, open-label, phase 3 trial. Lancet Oncol 2016; 17: 1061–9.

Examples

summary(HYPRO_2A)

kmplot(HYPRO_2A)

raredd/kmdata documentation built on June 15, 2025, 9:33 a.m.